Compass Pathways Plc ADR (CMPS) Stock Price, Quote & News

Company Profile

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incor...

Industry: Medical Care Facilities

Sector: Healthcare

Website: compasspathways.com

Address:

33 Broadwick Street, London, United Kingdom

PsychedStocks Oct. 27 at 8:34 PM

$CYBN $CMPS $ATAI $MNMD $SPY

0 · Reply

cyriak2 Oct. 27 at 6:56 PM

Bought $CMPS at $3 and $CYBN at $30. We'll see which one wins from here

0 · Reply

macrossluvsrobotech Oct. 27 at 6:43 PM

$CMPS NICE "I’m going to test psilocybin as a longevity therapy." https://x.com/bryan_johnson/status/1982826028641947819?s=46 $ATAI

2 · Reply

LiquidThetaOptions Oct. 27 at 10:34 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CMPS Current Share Price: $6.28 Contracts: $CMPS January 15, 2027 $7 Calls Scale in: $2.29- $2.81 Scale out: $3.57-$4.59 Can Easily Capture: 60% ROI Blended DTE: 446 Days | Join Elites here: https://liquidtheta.com

0 · Reply

LiquidThetaOptions Oct. 24 at 10:25 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CMPS Current Share Price: $6.34 Contracts: $CMPS January 15, 2027 $7 Calls Scale in: $1.90- $2.32 Scale out: $2.96-$3.80 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

Canvasback33 Oct. 23 at 1:52 PM

$CMPS this is such a pivotal moment in mental health history. When they get the nod it will change this space forever. Books will refer to it as BP (before psylocybin) and AP. What an exciting time to be alive.

0 · Reply

ClownThePoet Oct. 22 at 7:04 PM

$CMPS closing green

0 · Reply

ClownThePoet Oct. 22 at 5:41 PM

$CMPS my buddy told me Shrooms cured him from depression, addiction and alcoholism. HOW CAN U BE BEARISH

2 · Reply

Jormungand Oct. 22 at 5:37 PM

$CMPS Fuck. Should've sold at 7 and rebuy lower. 🤦been doing that on the way up, and one office meeting distracted me, ffs

3 · Reply

Stoneape Oct. 22 at 4:55 PM

$CMPS

0 · Reply

COMPASS Pathways Plc (CMPS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 4, 2025, 4:56 AM EDT - 7 weeks ago

COMPASS Pathways Plc (CMPS) Presents At Cantor Global Healthcare Conference 2025 Transcript

Sep 2, 2025, 6:30 AM EDT - 7 weeks ago

Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

Aug 27, 2025, 6:30 AM EDT - 2 months ago

Compass Pathways to Participate in Four Investor Conferences in September

Aug 5, 2025, 6:30 AM EDT - 2 months ago

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

Jul 31, 2025, 10:32 AM EDT - 3 months ago

COMPASS Pathways plc (CMPS) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

Jul 29, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways Appoints Justin Gover to Board of Directors

Jul 22, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

Jul 10, 2025, 4:00 PM EDT - 3 months ago

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

Jun 24, 2025, 2:47 PM EDT - 4 months ago

Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360

Jun 23, 2025, 8:25 AM EDT - 4 months ago

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

VZLA

Jun 23, 2025, 8:12 AM EDT - 4 months ago

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Jun 23, 2025, 6:48 AM EDT - 4 months ago

Compass Pathways' depression drug succeeds late-stage trial

Jun 23, 2025, 6:30 AM EDT - 4 months ago

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

May 14, 2025, 6:30 AM EDT - 5 months ago

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

May 8, 2025, 11:14 AM EDT - 6 months ago

COMPASS Pathways plc (CMPS) Q1 2025 Earnings Call Transcript

May 8, 2025, 6:30 AM EDT - 6 months ago

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

Apr 29, 2025, 6:30 AM EDT - 6 months ago

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Apr 28, 2025, 6:30 AM EDT - 6 months ago

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Apr 22, 2025, 6:00 AM EDT - 6 months ago

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Mar 28, 2025, 5:01 PM EDT - 7 months ago

This Is a Test From GlobeNewswire

ALVO

Mar 26, 2025, 6:30 AM EDT - 7 months ago

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Mar 18, 2025, 6:30 AM EDT - 7 months ago

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Mar 11, 2025, 6:30 AM EDT - 8 months ago

Compass Pathways to Participate in Stifel Virtual CNS Forum

Feb 28, 2025, 5:08 PM EST - 8 months ago

Compass Pathways: Betting On The Future Of Psilocybin Therapy

Feb 27, 2025, 4:02 PM EST - 8 months ago

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

Feb 27, 2025, 10:41 AM EST - 8 months ago

COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 6:30 AM EST - 8 months ago

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Feb 25, 2025, 4:00 PM EST - 8 months ago

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 6:30 AM EST - 8 months ago

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Feb 5, 2025, 6:30 AM EST - 9 months ago

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 21, 2025, 6:30 AM EST - 9 months ago

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Jan 10, 2025, 7:01 AM EST - 10 months ago

Compass Pathways Announces Pricing of Underwritten Offering

Dec 18, 2024, 6:30 AM EST - 11 months ago

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

Nov 25, 2024, 4:00 PM EST - 1 year ago

Compass Pathways to Participate in December Investor Conferences

Nov 14, 2024, 7:44 AM EST - 1 year ago

Compass Pathways to participate in Stifel 2024 Healthcare Conference

Nov 5, 2024, 6:58 AM EST - 1 year ago

Top 3 Health Care Stocks You'll Regret Missing In November

PACS SGHT

Nov 1, 2024, 5:10 PM EDT - 1 year ago

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

Oct 31, 2024, 2:49 PM EDT - 1 year ago

COMPASS Pathways plc (CMPS) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Oct 24, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

Sep 23, 2024, 7:00 AM EDT - 1 year ago

Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

Aug 28, 2024, 6:00 AM EDT - 1 year ago

Compass Pathways to participate in three investor conferences in September

Aug 15, 2024, 12:30 PM EDT - 1 year ago

Psychedelic Stocks: Focus On Their Cash

MNMD

Aug 12, 2024, 12:12 PM EDT - 1 year ago

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

ATAI CYBN MNMD

Aug 4, 2024, 1:22 AM EDT - 1 year ago

COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways announces second quarter 2024 financial results and business highlights

Jul 24, 2024, 7:01 AM EDT - 1 year ago

Compass Pathways to announce second quarter financial results on August 1, 2024

Jul 8, 2024, 10:11 AM EDT - 1 year ago

Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies

PsychedStocks Oct. 27 at 8:34 PM

$CYBN $CMPS $ATAI $MNMD $SPY

0 · Reply

cyriak2 Oct. 27 at 6:56 PM

Bought $CMPS at $3 and $CYBN at $30. We'll see which one wins from here

0 · Reply

macrossluvsrobotech Oct. 27 at 6:43 PM

$CMPS NICE "I’m going to test psilocybin as a longevity therapy." https://x.com/bryan_johnson/status/1982826028641947819?s=46 $ATAI

2 · Reply

LiquidThetaOptions Oct. 27 at 10:34 AM

0 · Reply

LiquidThetaOptions Oct. 24 at 10:25 PM

0 · Reply

Canvasback33 Oct. 23 at 1:52 PM

0 · Reply

ClownThePoet Oct. 22 at 7:04 PM

$CMPS closing green

0 · Reply

ClownThePoet Oct. 22 at 5:41 PM

$CMPS my buddy told me Shrooms cured him from depression, addiction and alcoholism. HOW CAN U BE BEARISH

2 · Reply

Jormungand Oct. 22 at 5:37 PM

$CMPS Fuck. Should've sold at 7 and rebuy lower. 🤦been doing that on the way up, and one office meeting distracted me, ffs

3 · Reply

Stoneape Oct. 22 at 4:55 PM

$CMPS

0 · Reply

prismmarketview Oct. 22 at 3:55 PM

PRISM BioView Dive: Psychedelics are moving from counterculture to clinical credibility. With the market projected to hit $11B by 2034, biotech leaders like $MNMD, $ATAI, and $CMPS are redefining mental health through data-driven, AI-enhanced therapeutics. https://prismmarketview.com/prism-bioview-dive-psychedelic-therapeutics-from-counterculture-to-clinical-breakthrough-heres-who-to-watch-once-dismissed-as-fringe-science-psychedelics-are-now-driving/

0 · Reply

Stoneape Oct. 22 at 2:13 PM

$CMPS this is ready to keep going up. Congrats bulls

0 · Reply

Phaethon7 Oct. 21 at 2:57 PM

$CMPS This is building a flag and coming hand in hand with $ATAI ... Random correlation or M/A ?

0 · Reply

DEhammerhead Oct. 20 at 11:03 PM

$CMPS

0 · Reply

LiquidThetaOptions Oct. 20 at 8:44 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CMPS Current Share Price: $6.52 Contracts: $CMPS January 15, 2027 $7 Calls Scale in: $2.84- $3.48 Scale out: $4.42-$5.69 Can Easily Capture: 60% ROI Blended DTE: 453 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

Goldenpoint9 Oct. 20 at 10:11 AM

$CMPS

0 · Reply

PhishTourFunds Oct. 19 at 3:48 AM

$CMPS $PSYG.CSE 🍄 🍄‍🟫 How two mushrooms took entirely different molecular pathways to ultimately create the same compound https://onlinelibrary.wiley.com/doi/full/10.1002/anie.202512017

0 · Reply

Jormungand Oct. 18 at 2:33 PM

$CMPS someone forgot to turn on the pump for this ticker 😭

0 · Reply

LiquidThetaOptions Oct. 18 at 11:30 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CMPS Current Share Price: $6.41 Contracts: $CMPS January 15, 2027 $7 Calls Scale in: $2.97- $3.63 Scale out: $4.62-$5.94 Can Easily Capture: 60% ROI Blended DTE: 455 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

ScottySalmon Oct. 17 at 10:36 PM

$CMPS cmon management sort out FDA. Atai did it and CMPS are far more advanced on its trials!

2 · Reply

DriuxP Oct. 17 at 7:49 PM

$ATAI $MNMD excellent performances out of these two today. $CMPS $PSIL $PBM

0 · Reply

Profitsalways Oct. 17 at 7:12 PM

$ATAI clear sector leader, $MNMD and $CMPS will do alright, someone’s gotta fail and that’s what $CYBN is for

1 · Reply

Market Cap	602.51M
Revenue (ttm)	0.00
Net Income (ttm)	-155.12M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.19

Volume	2,004,300
Avg Vol	1,662,778
Day's Range	N/A - N/A
Shares Out	95.94M
Stochastic %K	43%
Beta	2.21
Analysts	Strong Sell
Price Target	$15.60